VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Intralesional Acyclovir
Phase 3
Small molecule
R
Riphah International University
1
Indications
2
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Viral Wart
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Viral Wart
Phase 3
Recruiting
Clinical
Trials by Indication
[1]
Plantar Wart
1 trial
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
Unknown status
·
—
·
Phase 2/3
·
NCT06261684
·
92 enrolled
Viral Wart
1 trial
Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
Recruiting
·
R
Riphah International University
·
Approved
·
NCT07448844
·
40 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Intralesional Acyclovir. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Intralesional Acyclovir compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Intralesional Acyclovir. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Riphah International University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
R
Riphah International University
Related News